Financial information

The information source is the annual report of the company with business id 556258-6882

* Closing information (×1000) SEK

Fiscal year 202312 202212 202112
Number of months: 12 12
Turnover: 1,502,559 Revenue Down 1,631,945 Revenue Up 1,401,073
Financial expenses: 41,105 Revenue Up 15,851 Revenue Up 1,825
Earnings before taxes: 257,684 Revenue Down 324,904 Revenue Up 236,536
Total assets: 3,233,002 Revenue Up 2,343,656 Revenue Up 1,847,409
Current assets: 909,179 Revenue Up 723,440 Revenue Up 695,466
Current liabilities: 433,116 Revenue Up 427,379 Revenue Up 392,770
Equity capital: 1,580,722 Revenue Up 1,359,465 Revenue Up 1,092,998
Share capital: 24,846 Revenue Up 24,845 24,845
Number of employees: 578 Revenue Up 544 Revenue Up 516

Financial ratios

Solvency: 48.9% Revenue Down 58.0% Revenue Down 59.2%
Turnover per employee: 2,600 Revenue Down 3,000 Revenue Up 2,715
Profitability: 17.1% Revenue Down 19.9% Revenue Up 16.9%
Return on equity (ROE): 16.3% Revenue Down 23.9% Revenue Up 21.6%
Current ratio: 209.9% Revenue Up 169.3% Revenue Down 177.1%
Return on assets (ROA): 9.2% Revenue Down 14.5% Revenue Up 12.9%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202312
Number of months: 12
Turnover: 1,502,559
Financial expenses: 41,105
Earnings before taxes: 257,684
Total assets: 3,233,002
Current assets: 909,179
Current liabilities: 433,116
Equity capital: 1,580,722
Share capital: 24,846
Number of employees: 578

Financial ratios

Solvency: 48.9%
Turnover per employee: 2,600
Profitability: 17.1%
Return on equity (ROE): 16.3%
Current ratio: 209.9%
Return on assets (ROA): 9.2%